CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 79 enrolled
Drug / intervention
maravirocdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00850395
NCT00850395N/ACompleted
CompareCT.gov

Non-Interventional Study Of Celsentri® In Treatment Experienced Patients Infected With CCR5 Tropic HIV-1

ViiV Healthcare·observational·Posted Feb 25, 2009·Updated Nov 7, 2012

In Brief

An observational study evaluating maraviroc for HIV-1. Completed, enrolled 79 participants.

Detailed Summary

Aim of the study is to gain more knowledge about efficacy of CELSENTRI® in daily clinical practice and obtain information about the quality of life of patients using CELSENTRI®.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV-1
Countries--
CollaboratorsPfizer

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 25, 2009
Enrollment StartJul 1, 2009
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.4 years ago

Interventions

maravirocdrug

No intervention; any procedure at the discretion of the treating physician, in line with the SmPC